NCT00611559View on ClinicalTrials.gov

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

PHASE4CompletedINTERVENTIONAL
Enrollment

283

Participants

Timeline

Start Date

February 14, 2008

Primary Completion Date

June 25, 2008

Study Completion Date

June 25, 2008

Conditions
PoliomyelitisAcellular PertussisTetanusDiphtheriaHepatitis B
Interventions
BIOLOGICAL

Infanrix™ penta

Subjects received a booster dose

BIOLOGICAL

Infanrix™ hexa

Subjects received a booster dose

Trial Locations (3)

167000

GSK Investigational Site, Syktyvkar

183046

GSK Investigational Site, Murmansk

614022

GSK Investigational Site, Perm

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY